Small Pharma Inc.
DMTTF · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,494 | $2,901 | $3,624 | $2,721 |
| G&A Expenses | $2,735 | $687 | $3,502 | $4,731 |
| SG&A Expenses | $2,735 | $687 | $3,502 | $4,731 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,745 | $4,265 | $7,131 | $7,458 |
| Operating Income | -$5,632 | -$4,255 | -$7,128 | -$7,454 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$12 | -$3 | -$28 | -$3 |
| Pre-Tax Income | -$5,644 | -$4,258 | -$7,156 | -$7,456 |
| Tax Expense | $0 | -$1,885 | $0 | $0 |
| Net Income | -$5,644 | -$2,373 | -$7,156 | -$7,456 |
| % Margin | – | – | – | – |
| EPS | -0.018 | -0.007 | -0.022 | -0.023 |
| % Growth | -151.4% | 68.5% | 3.9% | – |
| EPS Diluted | -0.018 | -0.007 | -0.022 | -0.023 |
| Weighted Avg Shares Out | 321,562 | 321,470 | 321,806 | 322,427 |
| Weighted Avg Shares Out Dil | 321,562 | 321,470 | 321,806 | 322,427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $113 | $10 | $3 | $4 |
| Interest Expense | $8 | $0 | $0 | $0 |
| Depreciation & Amortization | $86 | $31 | $6 | $6 |
| EBITDA | -$5,546 | -$4,224 | -$7,123 | -$7,448 |
| % Margin | – | – | – | – |